Methanandamide
Jump to navigation
Jump to search
| File:Methanandamide.png | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Other names | AM-356, arachidonyl-1' -hydroxy-2'-propylamide |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| Chemical and physical data | |
| Formula | C23H39NO2 |
| Molar mass | 361.561 g/mol |
| 3D model (JSmol) | |
| |
Methanandamide, or N-(2-hydroxy-1R-methylethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide, is a synthetically created stable chiral analog of anandamide. Its effects have been observed to act on the cannabinoid receptors (specifically on CB1 receptors, which are part of the central nervous system) found in different organisms such as mammals, fish, and certain invertebrates (i.e. Hydra).
| Stub icon | This biochemistry article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Articles with short description
- Pages with broken file links
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Carboxylate esters
- Amides
- Cannabinoids
- All stub articles
- Biochemistry stubs